No he said it is worth $42 million right now, or .19 PPS... not including the diagnostic platforms which have the potential for $800 million/year revenue in the medium-future. So by his analysis we are grossly undervalued right now.
In 2027 (according to his timelines which I don't really agree with) if everything goes well it would be a $10 billion drug... hence the name of his article "What would you pay, right now, for a $10 billion drug in 2027?"
Market Data 
Markets 
AI
